IDXX Stock: IDEXX Laboratories, Inc. Stock Price, Analysis & Insights
Get live IDXX stock price $568.42, comprehensive IDEXX Laboratories, Inc. stock analysis, charts, news, and expert forecast. Real-time IDXX stock data and investment insights.
Loading chart data...
IDEXX Laboratories, Inc. (IDXX) Overview
IDEXX Laboratories, Inc. (IDXX) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, IDXX trades at $568.42 with a market capitalization of 44.84B . Over the past 52 weeks, IDXX has traded between $506.91 and $769.98 , with the current price positioned at approximately 23% of this range . Th...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 44.84B
- Current price: $568.42
- 52-week range: $506.91 - $769.98
- P/E ratio: 41.80
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dair...
Company Information
- CEO
- Jonathan J. Mazelsky
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 11000
Contact Information
- Website
- https://www.idexx.com
- Address
- One IDEXX Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 41.8)
✓ Higher growth potential with elevated volatility (Beta: 1.54)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for IDEXX Laboratories, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for IDEXX Laboratories, Inc.
- ⚠Investors should consider how IDEXX Laboratories, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 41.8) requires strong growth to justify
Market Cap
44.84B
P/E Ratio (TTM)
41.80
Beta
1.54
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare IDXX with peer companies:
- Price
- $135.54
- Market cap
- 38.28B
- Price
- $297.80
- Market cap
- 39.76B
- Price
- $881.93
- Market cap
- 54.58B
- Price
- $149.98
- Market cap
- 54.34B
- Price
- $217.72
- Market cap
- 50.99B
- Price
- $280.70
- Market cap
- 54.61B
- Price
- $86.34
- Market cap
- 49.71B
- Price
- $186.47
- Market cap
- 31.12B
- Price
- $166.78
- Market cap
- 27.22B
- Price
- $82.06
- Market cap
- 34.40B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.